Treatment with the PPARα agonist fenofibrate improves the efficacy of CD8+ T cell therapy for melanoma
Adoptive transfer of tumor antigen-specific CD8+ T cells can limit tumor progression but is hampered by the T cells’ rapid functional impairment within the tumor microenvironment (TME). This is in part caused by metabolic stress due to lack of oxygen and glucose. Here, we report that fenofibrate tre...
Main Authors: | Mohadeseh Hasanpourghadi, Arezki Chekaoui, Sophia Kurian, Raj Kurupati, Robert Ambrose, Wynetta Giles-Davis, Amara Saha, Xu Xiaowei, Hildegund C.J. Ertl |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Molecular Therapy: Oncolytics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770523000931 |
Similar Items
-
PPARγ Agonists: Emergent Therapy in Endometriosis
by: Alexandre Vallée, et al.
Published: (2021-06-01) -
Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet
by: Ying Zhang, et al.
Published: (2022-09-01) -
Activation of PPARα by Fenofibrate Attenuates the Effect of Local Heart High Dose Irradiation on the Mouse Cardiac Proteome
by: Omid Azimzadeh, et al.
Published: (2021-12-01) -
Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
by: Carmen Ciavarella, et al.
Published: (2020-04-01) -
PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales
by: Francesca Colapietro, et al.
Published: (2023-01-01)